(19)
(11) EP 4 551 609 A2

(12)

(88) Date of publication A3:
22.02.2024

(43) Date of publication:
14.05.2025 Bulletin 2025/20

(21) Application number: 23741620.1

(22) Date of filing: 07.07.2023
(51) International Patent Classification (IPC): 
C07K 16/36(2006.01)
A61K 31/00(2006.01)
A61K 39/395(2006.01)
A61K 47/68(2017.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/36; C07K 2317/569; C07K 2317/22; C07K 2317/31; A61K 2039/505; A61K 2039/542; C07K 2317/94; C07K 2317/40; A61K 39/39591; A61K 39/3955; C07K 2317/56; A61K 47/543; A61K 31/20; A61K 31/455
 
C-Sets:
  1. A61K 39/3955, A61K 2300/00;
  2. A61K 31/20, A61K 2300/00;
  3. A61K 31/455, A61K 2300/00;

(86) International application number:
PCT/EP2023/068805
(87) International publication number:
WO 2024/008904 (11.01.2024 Gazette 2024/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 08.07.2022 EP 22183825

(71) Applicant: Novo Nordisk A/S
2880 Bagsvaerd (DK)

(72) Inventors:
  • VEGGE, Andreas
    2880 Bagsværd (DK)
  • GRANATA, Daniele
    2880 Bagsværd (DK)
  • JOHANSSON, Eva
    2880 Bagsværd (DK)
  • BJELKE, Jais Rose
    2880 Bagsværd (DK)
  • LUND, Jacob
    2880 Bagsværd (DK)
  • SASSENE, Philip Jonas
    2880 Bagsværd (DK)
  • GREISEN, Per, J.
    2880 Bagsværd (DK)
  • EGEBJERG, Thomas
    2880 Bagsværd (DK)
  • HUBALEK, Frantisek
    2880 Bagsværd (DK)
  • FULLE, Simone
    2880 Bagsværd (DK)
  • NORRMAN, Mathias
    2880 Bagsværd (DK)
  • BUYSE, Marie-Ange
    9820 Merelbeke (BE)
  • DE TAVERNIER, Evelyn
    9831 Deurle (BE)
  • STEFFENSEN, Soren
    1040 Etterbeek (BE)

   


(54) HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)